Search research articles
Contact Us
Filters
Showing results (871-880 of 903) with videos related to
Page
of 91
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 27, 2022
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced <i>BRAF</i>-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134
Michael B Atkins, Sandra J Lee, Bartosz Chmielowski, et al.
The Journal of Urology
|
February 16, 2023
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort
Peter S Kirk, Yair Lotan, Homayoun Zargar, et al.
European Urology Focus
|
August 11, 2020
Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium
Maria Carmen Mir, Michele Marchioni, Homi Zargar, et al.
World Journal of Urology
|
August 9, 2021
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer
David D'Andrea, Peter C Black, Homayoun Zargar, et al.
World Journal of Urology
|
September 28, 2022
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer
Sarah M H Einerhand, Anna J Black, Homayoun Zargar, et al.
Urologic Oncology
|
February 15, 2020
Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer
David D'Andrea, Peter C Black, Homayoun Zargar, et al.
World Journal of Urology
|
June 9, 2018
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy
N Vasdev, H Zargar, J P Noël, et al.
Urologic Oncology
|
November 3, 2019
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy
Anna J Black, Homayoun Zargar, Kamran Zargar-Shoshtari, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 7, 2018
Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study
Kiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
JAMA
|
March 7, 2018
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer
Amar U Kishan, Ryan R Cook, Jay P Ciezki, et al.
Page
of 91
Search research articles
Search
Showing results (871-880 of 903) with videos related to
Sort By:
Page
of 91
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 27, 2022
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced <i>BRAF</i>-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134
Michael B Atkins, Sandra J Lee, Bartosz Chmielowski, et al.
The Journal of Urology
|
February 16, 2023
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort
Peter S Kirk, Yair Lotan, Homayoun Zargar, et al.
European Urology Focus
|
August 11, 2020
Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium
Maria Carmen Mir, Michele Marchioni, Homi Zargar, et al.
World Journal of Urology
|
August 9, 2021
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer
David D'Andrea, Peter C Black, Homayoun Zargar, et al.
World Journal of Urology
|
September 28, 2022
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer
Sarah M H Einerhand, Anna J Black, Homayoun Zargar, et al.
Urologic Oncology
|
February 15, 2020
Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer
David D'Andrea, Peter C Black, Homayoun Zargar, et al.
World Journal of Urology
|
June 9, 2018
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy
N Vasdev, H Zargar, J P Noël, et al.
Urologic Oncology
|
November 3, 2019
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy
Anna J Black, Homayoun Zargar, Kamran Zargar-Shoshtari, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 7, 2018
Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study
Kiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
JAMA
|
March 7, 2018
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer
Amar U Kishan, Ryan R Cook, Jay P Ciezki, et al.
Page
of 91